Browse
Submit Data
Databases
API
Help

Dataset Information

15 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

2-[2-(2-Pyrid-yl)eth-yl]isoindolinium perchlorate.

ABSTRACT: In the title salt, C(15)H(17)N(2) (+)·ClO(4) (-), the isoindoline N atom is protonated and an intra-molecular N-H?N hydrogen bond occurs. In the crystal, N-H?O and numerous weak C-H?O inter-actions occur between the cation and anion. The O atoms of the perchlorate anion are disordered over four sets of sites with occupancies of 0.438?(4), 0.270?(9), 0.155?(8) and 0.138?(5).

SUBMITTER: Butcher RJ

PROVIDER: S-EPMC2970132 | biostudies-literature | 2009 Aug

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

2-[2-(2-Pyrid-yl)eth-yl]isoindolinium perchlorate.

Butcher Ray J RJ Tesema Yohannes T YT Yisgedu Teshome B TB Gultneh Yilma Y

Acta crystallographica. Section E, Structure reports online 20090819 Pt 9

In the title salt, C(15)H(17)N(2) (+)·ClO(4) (-), the isoindoline N atom is protonated and an intra-molecular N-H⋯N hydrogen bond occurs. In the crystal, N-H⋯O and numerous weak C-H⋯O inter-actions occur between the cation and anion. The O atoms of the perchlorate anion are disordered over four sets of sites with occupancies of 0.438 (4), 0.270 (9), 0.155 (8) and 0.138 (5). ...[more]

PMID: 21577581

Similar Datasets

Di-?-bromido-bis-({bis-[2-(2-pyrid-yl)eth-yl]amine}copper(II)) bis-(perchlorate).

Project description:Each Cu atom in the dinuclear centrosymmetric title complex, [Cu(2)Br(2)(C(14)H(17)N(3))(2)](ClO(4))(2), is ligated in a distorted square-pyramidal geometry (? = 0.31) by a tridentate bis-[2-(2-pyrid-yl)eth-yl]amine ligand, and by two bridging Br atoms. In addition, the dinuclear species is stabilized by two hydrogen-bonded perchlorate anions.

| S-EPMC2960247 | biostudies-literature

Di-?-chlorido-bis-{[2-({[2-(2-pyrid-yl)eth-yl](2-pyridylmeth-yl)amino}meth-yl)phenol]zinc(II)} bis-(perchlorate) dihydrate.

Project description:The title compound, [Zn(2)Cl(2)(C(20)H(21)N(3)O)(2)](ClO(4))(2)·2H(2)O, consists of a dinuclear Zn(II) cationic complex, two disordered perchlorate anions and two water mol-ecules as solvate. The [Zn(2)(?-Cl)(2)(HL)(2)](2+ )cation [HL is 2-({[2-(2-pyrid-yl)eth-yl](2-pyridylmeth-yl)amino}meth-yl)phenol] has a centrosymmetric structure with the Zn(II) ions in a distorted octa-hedral environment surrounded by an N(3)OCl(2) donor set. HL acts as a tetra-dentate ligand through three N atoms from one amine group and two pyridyl arms and one O atom from the phenolic arm. The three N-donor sites of the HL ligand are arranged in meridional fashion, with the pyridine rings coordinated in trans positions with respect to each other. Consequently, the amine and phenol groups are trans to the asymmetric di-?-chlorido exogenous bridges. A polymeric chain is formed along [010] by C(12)R(4) (2)(8) inter-molecular hydrogen bonding. The perchlorate anion is disordered and was modelled by two sites in a 0.345?(18):0.655?(18) ratio. Water-perchlorate O-H?O inter-actions form cyclic structures, while phenol-water O-H?O inter-actions generate an infinite chain. In addition, weak inter-molecular C-H??(Ph) inter-actions between pyridine donor and phenol acceptor groups of neighboring cations build a two-dimensional polymeric structure parallel to (110).

| S-EPMC2979697 | biostudies-literature

4-(4-Pyrid-yl)pyridinium perchlorate methanol solvate.

Project description:In the cation of the title hydrated molecular salt, C(10)H(9)N(2) (+)·ClO(4) (-)·CH(3)OH, the dihedral angle formed by the pyridine rings is 28.82?(15)°. The crystal structure is stabilized by inter-molecular N-H?O and O-H?N hydrogen bonds and ?-? stacking inter-actions, with centroid-to-centroid distances of 3.5913?(7) and 3.6526?(7)?Å. Three O atoms of the perchlorate anion are disordered over two positions with refined occupancy factors of 0.649?(7):0.351?(7).

| S-EPMC2979109 | biostudies-literature

Bis[2-(2-pyridyl-sulfan-yl)eth-yl]ammonium perchlorate.

Project description:The cation and anion of the title salt, C(14)H(18)N(3)S(2) (+)·ClO(4) (-), lie on a twofold rotation axis. The cation is a W-shaped entity with the aromatic rings at the ends; the ammonium NH(2) (+) group is a hydrogen-bond donor to the pyridyl N atoms. The perchlorate ion has one O atom disordered over two sites in a 0.50:0.50 ratio.

| S-EPMC3008095 | biostudies-literature

N-(6-{2-[6-(2,2-Dimethyl-propanamido)-2-pyrid-yl]eth-yl}-2-pyrid-yl)-2,2-dimethyl-propanamide.

Project description:The title compound, C(22)H(30)N(4)O(2), lies about a crystallographic inversion center. The whole mol-ecule is disordered over two positions with a refined occupancy ratio of 0.636?(10):0.364?(10). The pyridine rings are approximately planar, with maximum deviations of 0.033?(10) and 0.063?(17)?Å for the major and minor components, respectively. The mean planes of the pyridine rings form dihedral angles of 17?(2)° in the major component and 18?(2)° in the minor component with the respective formamide groups attached to them. In the crystal packing, inter-molecular N-H?O and C-H?O hydrogen bonds link the mol-ecules into two-dimensional networks parallel to the ab plane.

| S-EPMC3007361 | biostudies-literature

Tris{2-[4-(2-pyrid-yl)pyrimidin-2-ylsulfan-yl]eth-yl}amine.

Project description:The tripodal character of the title compound, C(33)H(30)N(10)S(3), arises from the three thio-ether arms surrounding a central amine N atom. The three arms have approximately the same conformation but distinct geometries in a trans-trans-cis conformation, resulting in a short pyridine-sulfanyl N?S distance of 4.320?(7)?Å. The distances of the central N atom to the N atoms of three pyridine rings in the arms are 8.305?(7), 8.032?(7) and 5.076?(9)Å. In the crystal, mol-ecules are joined into a three-dimensional supra-molecular network via effective ?-? stacking between adjacent heterocycles [centroid-centroid distances of 3.700?(3)-4.118?(4)?Å between adjacent inter-layer pyrimidine rings and 3.676?(4)?Å between the pyridine rings].

| S-EPMC2977494 | biostudies-literature

Bis(?-bis-{[4-(2-pyrid-yl)pyrimidin-2-yl]sulfan-yl}methane)-disilver(I) bis-(perchlorate).

Project description:In the macrocyclic centrosymmetric dinuclear complex, [Ag(2)(C(19)H(14)N(6)S(2))(2)](ClO(4))(2), the Ag(I) atom, bis-{[4-(2-pyrid-yl)pyrimidin-2-yl]sulfan-yl}methane (2-bppt) ligand and perchlorate anion each lie on a twofold rotation axis. The 2-bppt ligand chelates two four-coordinated Ag(I) atoms through its two bipyridine-like arms. The O atoms of the perchlorate anion are disordered each over two positions of equal occupancy. Adjacent complex mol-ecules are linked by ?-? inter-actions between the pyridine and pyrimidine rings [centroid-centroid distance = 3.663?(8)?Å].

| S-EPMC3011527 | biostudies-literature

4-(2-Azaniumyl-eth-yl)piperazin-1-ium bis(perchlorate).

Project description:In the title compound, C(6)H(17)N(3) (2+)·2ClO(4) (-), the piperazine ring adopts a chair conformation with the ethyl-ammonium fragment occupying an equatorial position. In the crystal, the dications and perchlorate anions are linked through N-H⋯O hydrogen bonding and weak C-H⋯O hydrogen bonding into a three-dimensional supra-molecular network.

| S-EPMC3200960 | biostudies-literature

Tris[2-(2-pyridylsulfan-yl)eth-yl]ammonium perchlorate.

Project description:In the title molecular salt, C(21)H(25)N(4)S(3) (+)·ClO(4) (-), an intra-molecular N-H?N hydrogen bond stabilizes the conformation of the cation. The three N-C-C-S torsion angles are 91.7?(2), 100.9?(2) and 167.02?(14)°.

| S-EPMC2980172 | biostudies-other

1-(2-Cyano-ethyl)-2-(2-pyrid-yl)-1H,3H-benzimidazol-3-ium perchlorate.

Project description:The title compound, C(15)H(13)N(4) (+)·ClO(4) (-), comprises a nonplanar 1-(2-cyano-ethyl)-2-(2-pyrid-yl)-1H,3H-benzimidazol-3-ium cation [dihedral angle between the imidazole and pyridine rings = 22.5?(8)°] and a perchlorate anion. The cation is formed by protonation of the N atom of the benzimidazole ring. A charged N-H?O hydrogen bond connects the anion and cation, and inter-molecular C-H?O and C-H?N inter-actions contribute to the crystal packing.

| S-EPMC2979728 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data